Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Mai 23, 2026
Giyani Metals fera avancer l'étude de faisabilité définitive pour le projet K.Hill grâce à un nouveau financement de l'IDC
Giyani Metals to advance DFS for K.Hill project with new IDC funding
The panel is neutral to bullish on Giyani's IDC funding extension, with the main takeaway being that it provides more …
Xanadu : début public rare d'une société quantique photonique full-stack – Rapport d'initiation
Xanadu: Rare Public Debut March 27 of Full-Stack Photonic Quantum Company – Initiation Report
The panel is largely bearish on Xanadu's $3B valuation, citing significant commercialization risks, timeline uncertainties, and execution challenges despite the …
Les actions en hausse alors que le président Trump allège les menaces contre l'Iran
Stocks Rally as President Trump Eases Iran Threats
The panel agrees that the current rally is a relief-driven sentiment shift, but they are unanimous in their bearish stance …
Hegseth dit qu'il «faut de l'argent pour tuer les méchants» dans le cadre d'une poussée de dépenses de 200 milliards de dollars. Pourquoi Axon et L3Harris sont les 2 meilleures actions de défense à acheter maintenant
Hegseth Says It ‘Takes Money to Kill Bad Guys’ Amid $200 Billion Spending Push. Why Axon and L3Harris Are the 2 Top-Rated Defense Stocks to Buy Now
The panel consensus is bearish on AXON and LHX due to stretched valuations and uncertainty around geopolitical catalysts. Key risk …
Alors que Trump se prépare à une annonce sur les extraterrestres, achetez cet ETF maintenant pour investir dans les OVNIs
As Trump Readies an Alien Announcement, Buy This 1 ETF Now to Invest in UFOs
The panel is largely bearish on the Tuttle Capital UFO Disclosure ETF (UFOD), citing risks such as liquidity trap, high …
Clover Biopharmaceuticals rapporte des données positives de phase I américaine sur la revaccination contre le VRS chez les personnes âgées
Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV Re-Vaccination In Older Adults
Clover's Phase I data shows superior immunogenicity over AREXVY in a heterologous boost scenario, but Phase II efficacy data and …
Pourquoi le titre de Meta pourrait encore chuter
Why Meta Stock Could Fall Even Further
The panelists debated Meta's significant capital expenditure (capex) increase, with some seeing it as a risk due to uncertain returns …
Pourquoi l'action Venture Global a augmenté aujourd'hui
Why Venture Global Stock Rose Today
The panel consensus is bearish on Venture Global, citing high structural risk due to the company's high-cost U.S. LNG production, …
Le prix du pétrole chute alors que Trump évoque des négociations de paix avec l'Iran
Oil price slides as Trump talks up Iran peace negotiations
Despite a 6.6% drop in Brent crude, the Strait of Hormuz blockade remains a significant risk, with potential supply shortages …
Jack Smith a demandé des documents sur Kash Patel : Documents
Jack Smith Subpoenaed Records On Kash Patel: Documents
The panel discusses the political and institutional risks arising from subpoenas issued by Special Counsel Jack Smith targeting Kash Patel, …
2 des meilleures actions pétrolières à acheter maintenant et à conserver pendant des décennies
2 of the Best Oil Stocks to Buy Now and Hold for Decades
The panelists agreed that integrated majors like XOM and CVX have strong fundamentals for long-term holds due to their diversified …
Les actions taïwanaises pourraient subir d'autres dommages mercredi
Taiwan Stocks May Take Further Damage On Wednesday
Taiwan's market decline driven by external factors, primarily oil price rebound, with sector rotation rather than broad sell-off. Key risks …